Radiosurgical boost for primary high-grade gliomas

Journal of Neuro-Oncology

Volumn 57, Issue 2, 2002, Pages 151-160

  Prisco, F E ^a   Weltman, E ^a   Hanriot, R D M ^a   Brandt, R A ^a  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Anaplastic astrocytoma; Brain neoplasms; Glioblastoma multiforme; Radiation therapy; Radiosurgery

Indexed keywords

CISPLATIN; LOMUSTINE; PACLITAXEL; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; GLIOMA; HUMAN; MORTALITY; PATIENT SELECTION; PRIMARY HEALTH CARE; PROGNOSIS; RADIATION DOSE; RADIOSURGERY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME; DISEASE FREE SURVIVAL; FOLLOW UP; MIDDLE AGED; PATHOLOGY; SURVIVAL; TIME; TREATMENT OUTCOME;

ADULT; AGED; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; GLIOMA; HUMAN; MIDDLE AGE; RADIOSURGERY; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; HUMANS; MIDDLE AGED;

EID: 0035986191     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015757322379     Document Type: Article

References (33)

1. Neoplasms of the central nervous system
2. Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery
3. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A Medical Research Council trial
4. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study
5. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the Scandinavian Glioblastoma Study Group
6. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristina (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
7. Prognostic factors for high-grade malignant glioma: Development of a prognostic index. A report of the Medical Research Council Brain Tumour Working Party
8. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: A report using RTOG 90-06
9. Patterns of failure following high-dose 3-d conformal radiotherapy for high-grade astrocytomas: A quantitative dosimetric study
10. High activity iodine-125 implant for gliomas
11. A randomized trial of interstitial radiotherapy (RT) boost for newly diagnosed malignant glioma: Brain Tumor Cooperative Group (BTCG) Trial 8701
12. External irradiation followed by an interstitial high activity iodine-125 implant 'boost' in the initial treatment of malignant gliomas: NCOG study 6G-82-2
13. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme
14. Score index for stereotactic radiosurgery of brain metastases
15. Phase II, two-arm RTOG trial (94-11) of bischloroethylnitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (>20 or
16. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme
17. The radiobiology of radiosurgery: Rationale for different treatment regimens for AVMs and malignancies
18. The radiobiology of radiosurgery
19. Radiosurgery and fractionated radiation therapy: Comparison of different techniques in an in vivo rat glioma model
20. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms
21. Results of sterotactic brachytherapy used in the initial management of patients with glioblastoma
22. Linac radiosurgery for high-grade gliomas: The University of Florida experience
23. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas
24. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome
25. Stereotactic radiosurgery for glioblastoma: A final report of 31 patients
26. Radiosurgery for glioma patients: Hope or hype?
27. Radiosurgery for glioblastoma multiforme: The importance of selection criteria
28. Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: A report of Radiation Therapy Oncology Group 83-02
29. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials
30. Radiosurgery in the initial management of malignant gliomas: Survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group
31. Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage
32. Gamma knife for glioma: Selection factors and survival
33. Stereotactic radiosurgery for glioblastoma multiforme